NCT04141501View on ClinicalTrials.gov

Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 8, 2020

Primary Completion Date

March 14, 2023

Study Completion Date

September 14, 2023

Conditions
Alcohol Use Disorder
Interventions
DRUG

Psilocybin

single dose of psilocybin (25mg). orally in form of a capsule

DRUG

Placebo oral capsule

single dose of mannitol (100%)

Trial Locations (1)

8032

Psychiatrische Universitätsklinik Zürich, Zurich

All Listed Sponsors
collaborator

Schweizerischer Nationalfonds

OTHER

lead

University of Zurich

OTHER

NCT04141501 - Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients | Biotech Hunter | Biotech Hunter